4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0000950170-24-028609
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 400,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | 2024-03-06 | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | D | ||
Loading xslF345X05/ownership.xml…